The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study to evaluate chimeric antigen receptor (CAR) T cells incorporating a chlorotoxin tumor-targeting domain for patients with MMP2+ Recurrent or progressive glioblastoma (NCT04214392).
 
Behnam Badie
Stock and Other Ownership Interests - Atara Biotherapeutics; Atara Biotherapeutics (I); Cellectar; Cellectar (I); Inovio Pharmaceuticals; Inovio Pharmaceuticals (I); Sorrento Therapeutics; Sorrento Therapeutics (I)
Consulting or Advisory Role - Celularity; Chimeric Therapeutics
Patents, Royalties, Other Intellectual Property - MustangBio
 
Michael E Barish
Stock and Other Ownership Interests - Chimeric Therapeutics
Consulting or Advisory Role - Chimeric Therapeutics
Research Funding - Chimeric Therapeutics
Patents, Royalties, Other Intellectual Property - Chimeric Therapeutics
 
Ammar Chaudhry
Travel, Accommodations, Expenses - Siemens
 
Massimo D'Apuzzo
No Relationships to Disclose
 
Stephen J. Forman
Stock and Other Ownership Interests - Lixte Biotechnology; MustangBio
Consulting or Advisory Role - Alimera Sciences; Lixte Biotechnology; MustangBio; MustangBio
Research Funding - MustangBio
Patents, Royalties, Other Intellectual Property - MustangBio
 
Jana Portnow
No Relationships to Disclose
 
Shirong (Sean) Wang
No Relationships to Disclose
 
Julie A Ressler
No Relationships to Disclose
 
Jennifer Simpson
No Relationships to Disclose
 
Julie Kilpatrick
No Relationships to Disclose
 
Paige McNamara
No Relationships to Disclose
 
Jamie Wagner
Stock and Other Ownership Interests - Autolus; Iovance Biotherapeutics; Xencor
Research Funding - Chimeric Therapeutics; MustangBio
 
Suzette Blanchard
Research Funding - MustangBio
 
Dongrui Wang
No Relationships to Disclose
 
Christine Brown
Employment - Xencor (I)
Stock and Other Ownership Interests - Chimeric Therapeutics; MustangBio; Xencor
Consulting or Advisory Role - Aleta Biotherapeutics; Chimeric Therapeutics; MustangBio
Research Funding - Chimeric Therapeutics; MustangBio
Patents, Royalties, Other Intellectual Property - Chimeric Therapeutics; MustangBio